HORIBA_Medical_segment_image_Yumizen_hand

HORIBA Medical

Hématologie

HORIBA hematology

Chimie clinique

HORIBA Clinical Chemistry

Vétérinaire

HORIBA Medical

A Montpellier, HORIBA Medical conçoit, développe, produit puis distribue dans le monde entier, des automates de diagnostic in vitro dans les domaines de l'Hématologie, de la Chimie Clinique et de l'Hémostase. Ces instruments contribuent dès aujourd'hui à préparer la santé de demain.

   

Innovation - New HELO 2.0 Coming Soon

Yumizen G Hemostasis New Factor Assays

Dernières actualités d'HORIBA Medical

HORIBA_Medical_QSP_Newsletter_Image

Matutes score - HORIBA Medical QSP Newsletter #41

How can we differentiate Chronic Lymphocytic Leukemia (CLL) from other B-Cell Lymphoid Malignancies? The availability of a clinical decision algorithm…

Lire la suite

Leukemia - Yumizen Hematology Clinical Cases "Chase the Case" #26

Understanding a rare hematological malignancy like Plasma Cell Leukemia from simple complete blood count (CBC) analysis by utilizing hematology…

Lire la suite
HORIBA_Medical_QSP_Newsletter_Image

Anemia - HORIBA Medical QSP Newsletter #40

The 40th issue of the QSP Newsletter features Anemia. You will learn the symptoms, clinical workup process, and causes of Anemia. The case study of…

Lire la suite

Parcourir nos produits

Automation - HELO Solution
Automation - HELO Solution

Global Hematology Solution

Yumizen H Range
Yumizen H Range

Hematology Analyzer

Yumizen G Range
Yumizen G Range

Hemostasis Analyzer

Yumizen C Range
Yumizen C Range

Clinical Chemistry Analyzer

Pentra C Range
Pentra C Range

Clinical Chemistry Analyzer

Pentra 80 Range
Pentra 80 Range

Hematology Analyzer

Pentra 60 Range
Pentra 60 Range

Hematology Analyzer

Micros Range
Micros Range

Hematology Analyzer

CellaVision®
CellaVision®

Digital Cell Morphology Systems

Auto Compact Starrsed
Auto Compact Starrsed

Vitesse de sédimentation

Request for Information

Do you have any questions or requests? Use this form to contact our specialists.

* These fields are mandatory.

Corporate